Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Rosti

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Expert Opinion on Biological Therapy|September 23, 2014
High-dose chemotherapy for germ cell tumors: do we have a model?Andrea Necchi, Francesco Lanza, Giovanni Rosti, et al.
European Journal of Cancer Care|December 23, 2016
Patients' perception of chemotherapy side effects: Expectations, doctor-patient communication and impact on quality of life - An Italian surveyDomenica Lorusso, Emilio Bria, Anna Costantini, et al.
Cancer Control : Journal of the Moffitt Cancer Center|February 25, 2003
High-dose chemotherapy in adult patients with germ cell tumorsUgo De Giorgi, Giorgio Papiani, Giuseppe Severini, et al.
Journal of the National Cancer Institute. Monographs|June 12, 2015
High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation for High-Risk Primary Breast CancerPaolo Pedrazzoli, Massimo Martino, Sara Delfanti, et al.
Tumori|July 27, 2011
Expectations of survivors, caregivers and healthcare providers for testicular cancer survivorship and quality of lifeSilvia De Padova, Giovanni Rosti, Emanuela Scarpi, et al.
Oncology Reports|July 6, 2006
Dose and outcome: the hurdle of neutropenia (Review)Maurizio Marangolo, Carmelo Bengala, Pier Franco Conte, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 5, 2022
Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statementVincenzo Adamo, Lorenzo Antonuzzo, Marco Danova, et al.
Urologic Oncology|June 27, 2009
Long-term outcome of salvage high-dose chemotherapy in patients with germ cell tumor with poor prognostic featuresUgo De Giorgi, Giovanni Rosti, Roberto Salvioni, et al.
Recenti Progressi in Medicina|May 31, 2014
[Cancer on the big screen. How and when movies deal with oncological diseases]Luciano De Fiore, Anna Costantini, Massimo Di Maio, et al.
Nutrients|October 21, 2020
The Role of Nutritional Support in Cured/Chronic PatientsGiovanni Rosti, Fabrizio Romano, Simona Secondino, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Expert Opinion on Biological Therapy|September 23, 2014
High-dose chemotherapy for germ cell tumors: do we have a model?Andrea Necchi, Francesco Lanza, Giovanni Rosti, et al.
European Journal of Cancer Care|December 23, 2016
Patients' perception of chemotherapy side effects: Expectations, doctor-patient communication and impact on quality of life - An Italian surveyDomenica Lorusso, Emilio Bria, Anna Costantini, et al.
Cancer Control : Journal of the Moffitt Cancer Center|February 25, 2003
High-dose chemotherapy in adult patients with germ cell tumorsUgo De Giorgi, Giorgio Papiani, Giuseppe Severini, et al.
Journal of the National Cancer Institute. Monographs|June 12, 2015
High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation for High-Risk Primary Breast CancerPaolo Pedrazzoli, Massimo Martino, Sara Delfanti, et al.
Tumori|July 27, 2011
Expectations of survivors, caregivers and healthcare providers for testicular cancer survivorship and quality of lifeSilvia De Padova, Giovanni Rosti, Emanuela Scarpi, et al.
Oncology Reports|July 6, 2006
Dose and outcome: the hurdle of neutropenia (Review)Maurizio Marangolo, Carmelo Bengala, Pier Franco Conte, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 5, 2022
Supportive therapies in the prevention of chemotherapy-induced febrile neutropenia and appropriate use of granulocyte colony-stimulating factors: a Delphi consensus statementVincenzo Adamo, Lorenzo Antonuzzo, Marco Danova, et al.
Urologic Oncology|June 27, 2009
Long-term outcome of salvage high-dose chemotherapy in patients with germ cell tumor with poor prognostic featuresUgo De Giorgi, Giovanni Rosti, Roberto Salvioni, et al.
Recenti Progressi in Medicina|May 31, 2014
[Cancer on the big screen. How and when movies deal with oncological diseases]Luciano De Fiore, Anna Costantini, Massimo Di Maio, et al.
Nutrients|October 21, 2020
The Role of Nutritional Support in Cured/Chronic PatientsGiovanni Rosti, Fabrizio Romano, Simona Secondino, et al.
Pageof 9